Product NDC: | 55390-175 |
Proprietary Name: | Fosphenytoin Sodium |
Non Proprietary Name: | Fosphenytoin Sodium |
Active Ingredient(s): | 50 mg/mL & nbsp; Fosphenytoin Sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-175 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077481 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070806 |
Package NDC: | 55390-175-10 |
Package Description: | 10 VIAL in 1 BOX (55390-175-10) > 2 mL in 1 VIAL |
NDC Code | 55390-175-10 |
Proprietary Name | Fosphenytoin Sodium |
Package Description | 10 VIAL in 1 BOX (55390-175-10) > 2 mL in 1 VIAL |
Product NDC | 55390-175 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fosphenytoin Sodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20070806 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | FOSPHENYTOIN SODIUM |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |